Advanced non-small cell lung cancer
Clinical trials for Advanced non-small cell lung cancer explained in plain language.
Never miss a new study
Get alerted when new Advanced non-small cell lung cancer trials appear
Sign up with your email to follow new studies for Advanced non-small cell lung cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lung cancer immune cell therapy study stopped early after just 2 patients
Disease control Stopped earlyThis study tested a treatment called GT201, which uses immune cells taken from a patient's own tumor to attack advanced lung cancer. It was designed for adults aged 18-70 with non-small cell or small cell lung cancer that had stopped responding to standard treatments. The study w…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Lung cancer drug trial halted early: what we know
Disease control Stopped earlyThis early-stage trial tested a new drug called MYTX-011 for people with advanced non-small cell lung cancer (NSCLC) that had spread or come back after standard treatments. The drug is an antibody-drug conjugate designed to deliver a powerful chemotherapy directly to cancer cells…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Phase 1 • Sponsor: Mythic Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC